| |
|
|
|
Proteostasis Ther  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
1.38 
|
|
High: |
|
Low: |
|
Resistance:
|
1.18
1.31
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
0.98
0.82
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.15
|
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
1.11  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
1.19 |
Stochastic Oscillator |
%K(14,3):
|
45.45 |
|
MA(250): |
1.40 |
%D(3): |
49.49 |
|
Average Volume(K) |
3-Month: |
56926
|
52-Week |
High:
|
2.47 |
|
10-Days: |
108248 |
Low: |
0.87 |
|
RSI |
RSI(14):
|
49.29 |
Change(%): |
-54.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.747 |
Return on Equity (ttm) |
-72.4 |
Shares Out. (M) |
52.18 |
|
EPS Est. Current Year |
-2.750 |
Return on Assets (ttm) |
-31.2 |
Shares Float (M) |
41.43 |
|
EPS Est. Next Year |
-2.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.30 |
|
EPS Est. Next Quarter |
-0.750 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.62 |
|
Forward EPS |
-1.160 |
Gross Profit (p.s.) |
0.096 |
Shares Short (K) |
1310 |
|
Book Value (p.s.) |
0.710 |
EBITDA (p.s.) |
-0.682 |
P/E |
-1.49 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.56 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.84 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-24.28 |
P/CF |
-1.42 |
|
|
|
|
|
|
